标题
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer
作者
关键词
-
出版物
Biomolecules
Volume 12, Issue 2, Pages 203
出版商
MDPI AG
发表日期
2022-01-26
DOI
10.3390/biom12020203
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncogenic Ras disrupts epithelial integrity by activating the transmembrane serine protease hepsin
- (2021) Topi A. Tervonen et al. CANCER RESEARCH
- Prostate cancer
- (2021) Richard J. Rebello et al. Nature Reviews Disease Primers
- Prostate-specific Antigen Screening Using the Traditional Cut Point of 3 ng/ml: Con
- (2021) Peter C. Albertsen European Urology Focus
- Prostate cancer screening: a new way forward or another false start?
- (2021) Peter C. Albertsen Nature Reviews Urology
- The transmembrane serine protease hepsin suppresses type I interferon induction by cleaving STING
- (2021) Fu Hsin et al. Science Signaling
- PSA testing, cancer treatment, and prostate cancer mortality reduction: What is the mechanism?
- (2021) Peter C. Albertsen UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
- (2020) Ufuk Degirmenci et al. Cells
- Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers
- (2020) Shoichiro Mukai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PI(3,4)P2 Signaling in Cancer and Metabolism
- (2020) Luca Gozzelino et al. Frontiers in Oncology
- Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
- (2020) Juyan Zheng et al. Molecular Cancer
- Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
- (2020) Ragheed Saoud et al. Cells
- Hepsin: a multifunctional transmembrane serine protease in pathobiology
- (2020) Shuo Li et al. FEBS Journal
- HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
- (2019) Fatemeh Moosavi et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
- (2019) John Kwon et al. Cancer Discovery
- A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
- (2018) Sarah Benafif et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cathepsin D enhances breast cancer invasion and metastasis through promoting hepsin ubiquitin-proteasome degradation
- (2018) Chunyi Zhang et al. CANCER LETTERS
- Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
- (2017) Paul L. Nguyen et al. EUROPEAN UROLOGY
- The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells
- (2017) Shang-Ru Wu et al. Scientific Reports
- The serine proteinase hepsin is an activator of pro-matrix metalloproteinases: molecular mechanisms and implications for extracellular matrix turnover
- (2017) David J. Wilkinson et al. Scientific Reports
- The PI3K AKT pathway in the pathogenesis of prostate cancer
- (2016) Xiaofei Wen Frontiers in Bioscience-Landmark
- Clinical and Biological Significance of Hepsin Overexpression in Breast Cancer
- (2016) Peng Xing et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
- (2015) Mikko Pelkonen et al. BMC CANCER
- Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
- (2015) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion
- (2015) T A Tervonen et al. ONCOGENE
- Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer
- (2015) Matthew J. Roberts et al. PROSTATE
- Plasma macrophage-stimulating protein and hepatocyte growth factor levels are associated with prostate cancer progression
- (2015) Satoru Sugie et al. Human Cell
- Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis
- (2015) Xi Tang et al. Oncotarget
- Matrix-Dependent Regulation of AKT in Hepsin-Overexpressing PC3 Prostate Cancer Cells
- (2015) Stephanie M Wittig-Blaich et al. NEOPLASIA
- Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with Prostatectomy
- (2014) Jay T. Bishoff et al. JOURNAL OF UROLOGY
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
- (2013) Nicholas Erho et al. PLoS One
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Characterization of the prostate cancer susceptibility geneKLF6in human and mouse prostate cancers
- (2012) Karen Chiam et al. PROSTATE
- Variants in the HEPSIN gene are associated with susceptibility to prostate cancer
- (2012) H J Kim et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis
- (2011) S Tsuji et al. BRITISH JOURNAL OF CANCER
- N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells
- (2011) Arun Kumar Nalla et al. EXPERIMENTAL CELL RESEARCH
- Hepsin immunohistochemical expression in prostate cancer in relation to Gleason′s grade and serum prostate specific antigen
- (2011) MadhuMati Goel et al. Indian Journal of Pathology and Microbiology
- Proteolytic Activation of Pro-Macrophage-Stimulating Protein by Hepsin
- (2011) R. Ganesan et al. MOLECULAR CANCER RESEARCH
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Type II Transmembrane Serine Protease (TTSP) deregulation in cancer
- (2010) Siobhan et al. Frontiers in Bioscience-Landmark
- Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells
- (2010) Manisha Tripathi et al. PROSTATE
- Association ofhepsingene variants with prostate cancer risk and prognosis
- (2010) Sarah K. Holt et al. PROSTATE
- Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA
- (2009) Kate A. Owen et al. BIOCHEMICAL JOURNAL
- Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
- (2009) M. S. Arredouani et al. CLINICAL CANCER RESEARCH
- Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model
- (2009) Srinivas Nandana et al. PROSTATE
- Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression
- (2008) Manisha Tripathi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and characterization of small-molecule inhibitors of hepsin
- (2008) John R. Chevillet et al. MOLECULAR CANCER THERAPEUTICS
- PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-κB in metastatic prostate cancer cells
- (2008) Tisheeka R. Graham et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now